Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: A 7-year tertiary centre analysis

Hematology

Volumn 16, Issue 4, 2011, Pages 213-220

  Anoop, Parameswaran ^a   Shaw, Bronwen E ^a,b   Riley, Unell ^a   Ethell, Mark E ^a   Taj, Mary ^a   Lancaster, Donna L ^a   Atra, Ayad ^a   Saso, Radovan ^a   Littlewood, Simon ^a   Mohammed, Kabir ^a   Davies, Faith ^a,c   Treleaven, Jennie ^a   Morgan, Gareth J ^a,c   Potter, Mike N ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Haematopoietic stem cell transplantation; Urotheliotropic viral haemorrhagic cystitis

Indexed keywords

ALEMTUZUMAB; CARMUSTINE; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; INFUSION FLUID; MELPHALAN; MESNA; PROBENECID; RIBAVIRIN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW SUPPRESSION; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; CYSTECTOMY; CYSTOSCOPY; DIATHERMY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVENING DOSAGE; FEMALE; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; HYDRATION; INCIDENCE; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; NEPHROTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TERTIARY HEALTH CARE; THROMBOCYTE TRANSFUSION; VIRUS INFECTION; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CYSTITIS; DATA COLLECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960131848     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453311X13025568941763     Document Type: Article

References (39)

1. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B. K.) isolated from urine after renal transplantation. Lancet 1971;1:1253-7.
2. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971;1:1257-60.
3. Harkensee C, Vasdev N, Gennery AR, Willetts IE, Taylor C. Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation: a systematic review and evidence-based guidance for clinical management. Br J Haematol 2008;142:717-31.
4. Leung AY, Yuen KY, Kwong YL. Polyoma BK: virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 2005;36:929-37.
5. Bogdanovic G, Priftakis P, Giraud G, Dalianis T. A related donor and reduced intensity conditioning reduces the risk of development of BK virus-positive haemorrhagic cystitis in allogeneic haematopoietic stem cell-transplanted patients. Anticancer Res 2006;26:1311-8.
6. Dropulic LK, Jones RJ. Polyomavirus BK: infection in blood and marrow transplant recipients. Bone Marrow Transplant 2008;41:11-8.
7. Decker DB, Karam JA, Wilcox DT. Pediatric hemorrhagic cystitis. J Pediatr Urol 2009;5:254-64.
8. Vogeli TA, Peinemann F, Burdach S, Ackermann R. Urological treatment and clinical course of BK polyomavirus-associated hemorrhagic cystitis in children after bone marrow transplantation. Eur Urol 1999;36:252-7.
9. Peinemann F, de Villiers EM, Dorries K, Adams O, Vogeli TA, Burdach S. Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants. Eur J Pediatr 2000;159:182-8.
10. Fioriti D, Degener AM, Mischitelli M, Videtta M, Arancio A, Sica S, et al. BKV infection and hemorrhagic cystitis after allogeneic bone marrow transplant. Int J Immunopathol Pharmacol 2005;18:309-16.
11. Hatakeyama N, Suzuki N, Yamamoto M, Kuroiwa Y, Hori T, Mizue N, et al. Detection of BK virus and adenovirus in the urine from children after allogeneic stem cell transplantation. Pediatr Infect Dis J 2006;25:84-5.
12. Cesaro S, Facchin C, Tridello G, Messina C, Calore E, Biasolo MA, et al. A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2008;41:363-70.
13. Leung AY, Mak R, Lie AK, Yuen KY, Cheng VC, Liang R, et al. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant 2002;29:509-13.
14. Asano Y, Kanda Y, Ogawa N, Sakata-Yanagimoto M, Nakagawa M, Kawazu M, et al. Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32:1175-9.
15. Gorczynska E, Turkiewicz D, Rybka K, Toporski J, Kalwak K, Dyla A, et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005;11:797-804.
16. Giraud G, Bogdanovic G, Priftakis P, Remberger M, Svahn BM, Barkholt L, et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica 2006;91:401-4.
17. Giraud G, Priftakis P, Bogdanovic G, Remberger M, Dubrulle M, Hau A, et al. BK viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts. Bone Marrow Transplant 2008;41:737-42.
18. Gaziev J, Paba P, Miano R, Germani S, Sodani P, Bove P, et al. Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. Biol Blood Marrow Transplant 2010;16:662-71.
19. Tomonari A, Takahashi S, Ooi J, Fukuno K, Takasugi K, Tsukada N, et al. Hemorrhagic cystitis in adults after unrelated cord blood transplantation: a single-institution experience in Japan. Int J Hematol 2006;84:268-71.
20. Silva Lde P, Patah PA, Saliba RM, Szewczyk NA, Gilman L, Neumann J, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 2010;95:1183-90.
21. Chakrabarti S, Osman H, Collingham K, Milligan DW. Polyoma viruria following T-cell-depleted allogeneic transplants using Campath-1H: incidence and outcome in relation to graft manipulation, donor type and conditioning. Bone Marrow Transplant 2003;31:379-86.
22. Childs R, Sanchez C, Engler H, Preuss J, Rosenfeld S, Dunbar C, et al. High incidence of adeno and polyomavirus induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 1998;22:889-93.
23. Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide induced hemorrhagic cystitis. Urology 1982;20:256-8.
24. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-8.
25. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003;9:215-33.
26. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009;15:1628-33.
27. Limaye AP, Jerome KR, Kuhr CS, Ferrenberg J, Huang ML, Davis CL, et al. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis 2001;183:1669-72.
28. Gibson PE, Knowles WA, Hand JF, Brown DW. Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Med Virol 1993;39:278-81.
29. Allard A, Albinsson B, Wadell G. Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis. J Clin Microbiol 2001;39:498-505.
30. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986;315:230-4.
31. Trotman J, Nivison-Smith I, Dodds A. Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration. Bone Marrow Transplant 1999;23:797-801.
32. Seber A, Shu XO, Defor T, Sencer S, Ramsay N. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999;23:35-50.
33. Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation 1993;56:875-9.
34. Cesaro S, Brugiolo A, Faraci M, Uderzo C, Rondelli R, Favre C, et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncologybone marrow transplantation group. Bone Marrow Transplant 2003;32:925-31.
35. Hale GA, Rochester RJ, Heslop HE, Krance RA, Gingrich JR, Benaim E, et al. Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. Biol Blood Marrow Transplant 2003;9:698-705.
36. El-Zimaity M, Saliba R, Chan K, Shahjahan M, Carrasco A, Khorshid O, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood 2004;103:4674-80.
37. Chakrabarti S, Mackinnon S, Chopra R, Kottaridis PD, Peggs K, O'Gorman P, et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 2002;99:4357-63.
38. Dodero A, Carrabba M, Milani R, Rizzo E, Raganato A, Montefusco V. Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed. Exp Hematol 2005;33:920-7.
39. Chakrabarti S, Milligan DW, Pillay D, Mackinnon S, Holder K, Kaur N, et al. Reconstitution of the Epstein-Barr virusspecific cytotoxic T-lymphocyte response following T-celldepleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. Blood 2003;102:839-42.